FDA Clears CoAlign Innovations’ AccuLIF Interbody Fusion Devices to Market

Redwood City, Calif.-based CoAlign Innovations received FDA market clearance for the AccuLIF XL lateral expandable interbody fusion device line.

Advertisement

The product line includes the AccuLIF TL for TLIF procedures and the AccuLIF PL for PLIF procedures. The systems are designed to be low profile with controlled expansion for precise anatomical reconstruction.

More Articles on Devices:
Smith & Nephew Allowed to Promote KFx Medical Rotator Cuff Repair Device
Australian Government Warns of LMT Surgical’s Arthroplasty Device Safety
Stryker Awarded $85.5M DOD Contract for Hip, Knee Implants

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.